James A. Robinson Jr.

Insider Reports History

Entity
Individual
Location
852 Winter Street, Waltham, MA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James A. Robinson Jr.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 150K Oct 2, 2023 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10K Aug 6, 2024 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 Nov 30, 2022 Direct

Insider Reports Filed by James A. Robinson Jr.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Aug 6, 2024 1 $0 4 Aug 8, 2024 Director
ELDN Eledon Pharmaceuticals, Inc. Oct 2, 2023 1 $233K 4 Oct 3, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Oct 1, 2023 0 $0 3 Oct 2, 2023 Director
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Director
URGN UroGen Pharma Ltd. Jul 25, 2023 1 $0 4/A Jul 28, 2023 Director
URGN UroGen Pharma Ltd. Jul 25, 2023 0 $0 3 Jul 27, 2023 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2022 1 $0 4 Dec 1, 2022 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 1 $0 4 Dec 2, 2021 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 0 $0 3 Dec 2, 2021 Director